Clinical Trial

Comparison of Holmium, Thulium:YAG, and Thulium Fiber Lasers in Prostate Enucleation

Study acronym: TRI-LASER
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Benign prostatic hyperplasia (BPH) is a common condition in aging men and may require surgical treatment when medical therapy is ineffective. Anatomical prostate enucleation using different laser technologies is a well-established surgical approach for the treatment of BPH. The purpose of this prospective randomized study is to compare the efficiency and safety of three commonly used laser systems-Holmium:YAG, Thulium:YAG, and Thulium Fiber Laser (TFL)-during anatomical prostate enucleation. The primary objective of the study is to evaluate laser efficiency by measuring grams of enucleated prostate tissue per joule (g/J) using intraoperative laser device data. Secondary outcomes include changes in International Prostate Symptom Score (IPSS) and the occurrence of postoperative urinary incontinence. All laser systems used in this study are part of routine clinical practice, and no additional diagnostic procedures or treatments will be performed for study purposes
Trial Details
NCT Number NCT07350005
Lead Sponsor Ankara University
Conditions BPH (Benign Prostatic Hyperplasia)
Enrollment 159 participants
Start Date 2026-05
Primary Completion 2027-11 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-20